Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Bacus, Sarah S.a; c | Gudkov, Andrei V.b | Esteva, Francisco J.c | Yarden, Yosefd
Affiliations: [a] Quantitative Diagnostics Laboratory, Elmhurst, IL 60126, USA | [b] Department of Genetics, University of Illinois - Chicago, College of Medicine, Chicago, IL, USA | [c] MD Anderson Cancer Center, Department of Breast Medical Oncology, Houston, TX, USA | [d] Weizmann Institute of Science, Rehovot, Israel
Abstract: Amplification and overexpression of the Her2/neu (c-erbB-2) growth factor receptor occurs in ~ 25% of early stage breast cancers. HER2/neu has been established as an important prognostic factor in early stage breast cancer in large patient populations and has been associated with shorter overall and disease free survival. New data are emerging to suggest that HER2/neu may be useful not only as a prognostic factor but also as a predictive marker for response to chemotherapeutics, anti-estrogens, and therapeutic regimens using anti-HER2/neu monoclonal antibodies. However, little is known of how other erbB receptors tyrosine kinases affect breast cancer biological behavior and response to therapy. In this review, we highlight recent data on Her2/neu as a prognostic and predictive marker of response to therapy, as well as how the other receptors of the erbB family affect the biological behavior of breast cancer.
DOI: 10.3233/BD-1999-11106
Journal: Breast Disease, vol. 11, no. 1, pp. 63-75, 1999
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]